Interferons in relapsing remitting multiple sclerosis: a systematic review Interferons in relapsing remitting multiple sclerosis: a systematic review2018-01-17T17:01:53-05:00
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis2018-01-17T17:01:13-05:00